Artwork

Content provided by James Jacobson and Dog Podcast Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by James Jacobson and Dog Podcast Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

A Daily Pill for Dog Lymphoma? The Promise of Monepantel Explained | Kim Agnew, BVSc #287

48:27
 
Share
 

Manage episode 493121727 series 1226127
Content provided by James Jacobson and Dog Podcast Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by James Jacobson and Dog Podcast Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Originally aired in 2023, Molly Jacobson interviews Dr. Kim Agnew about the groundbreaking trials of Monepantel, a sheep dewormer repurposed as a potential treatment for canine lymphoma. Discover the science behind this innovative therapy, its potential to stabilize lymphoma, and how it compares to traditional treatments like chemotherapy and prednisone.

Key Topics:

  • What is Monepantel, and how was it discovered?
  • The mechanism behind Monepantel's ability to target cancer cells.
  • Early trial results: Quality of life and stability for dogs with B-cell lymphoma.
  • How Monepantel compares to prednisone and chemotherapy.
  • Insights into ongoing and future clinical trials.
  • How dog lovers can participate in studies.

Your Voice Matters!

If you have a question for our team, or if you want to share your own hopeful dog cancer story, we want to hear from you! Go to https://www.dogcancer.com/ask to submit your question or story, or call our Listener Line at +1 808-868-3200 to leave a question.

Related Videos:

https://www.youtube.com/watch?v=_92w6TTXM5c

https://www.youtube.com/watch?v=uAZrPM1X8ww

Related Links:

PharmAust Dog Lymphoma Clinical Trial: https://www.pharmaust.com/petdogtrial/

Chapters:

00:00 Introduction

00:30 Meet Dr. Kim Agnew and Monepantel Overview

01:15 The Origin of Monepantel: From Dewormer to Cancer Fighter

03:30 How Monepantel Targets Cancer Cells

07:00 Insights on Clinical Trials for Canine Lymphoma

09:30 Benefits of Monepantel: A Daily Pill for Dogs

12:00 Comparing Monepantel to Chemotherapy and Prednisone

14:45 Early Trial Results: Stabilizing Lymphoma in Dogs

18:30 Why Lymphoma Was Chosen for Trials

20:00 Potential for Treating Other Cancers in Dogs

23:15 How to Enroll Dogs in Clinical Trials

26:45 Side Effects and Safety of Monepantel

31:00 Future Trials and Research Goals

34:30 Closing Thoughts and Resources

33:55 Closing Remarks and Resources

Get to know Kim Agnew, BVSc:

https://www.dogcancer.com/people/kim-agnew-bvsc/

For more details, articles, podcast episodes, and quality education, go to the episode page: https://www.dogcancer.com/podcast/

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

290 episodes

Artwork
iconShare
 
Manage episode 493121727 series 1226127
Content provided by James Jacobson and Dog Podcast Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by James Jacobson and Dog Podcast Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Originally aired in 2023, Molly Jacobson interviews Dr. Kim Agnew about the groundbreaking trials of Monepantel, a sheep dewormer repurposed as a potential treatment for canine lymphoma. Discover the science behind this innovative therapy, its potential to stabilize lymphoma, and how it compares to traditional treatments like chemotherapy and prednisone.

Key Topics:

  • What is Monepantel, and how was it discovered?
  • The mechanism behind Monepantel's ability to target cancer cells.
  • Early trial results: Quality of life and stability for dogs with B-cell lymphoma.
  • How Monepantel compares to prednisone and chemotherapy.
  • Insights into ongoing and future clinical trials.
  • How dog lovers can participate in studies.

Your Voice Matters!

If you have a question for our team, or if you want to share your own hopeful dog cancer story, we want to hear from you! Go to https://www.dogcancer.com/ask to submit your question or story, or call our Listener Line at +1 808-868-3200 to leave a question.

Related Videos:

https://www.youtube.com/watch?v=_92w6TTXM5c

https://www.youtube.com/watch?v=uAZrPM1X8ww

Related Links:

PharmAust Dog Lymphoma Clinical Trial: https://www.pharmaust.com/petdogtrial/

Chapters:

00:00 Introduction

00:30 Meet Dr. Kim Agnew and Monepantel Overview

01:15 The Origin of Monepantel: From Dewormer to Cancer Fighter

03:30 How Monepantel Targets Cancer Cells

07:00 Insights on Clinical Trials for Canine Lymphoma

09:30 Benefits of Monepantel: A Daily Pill for Dogs

12:00 Comparing Monepantel to Chemotherapy and Prednisone

14:45 Early Trial Results: Stabilizing Lymphoma in Dogs

18:30 Why Lymphoma Was Chosen for Trials

20:00 Potential for Treating Other Cancers in Dogs

23:15 How to Enroll Dogs in Clinical Trials

26:45 Side Effects and Safety of Monepantel

31:00 Future Trials and Research Goals

34:30 Closing Thoughts and Resources

33:55 Closing Remarks and Resources

Get to know Kim Agnew, BVSc:

https://www.dogcancer.com/people/kim-agnew-bvsc/

For more details, articles, podcast episodes, and quality education, go to the episode page: https://www.dogcancer.com/podcast/

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

290 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play